Vincent Luca

16PUBLICATIONS
61CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active moleculesApplied and developmental psychology not elsewhere classifiedTumour immunologyNanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Nov 02, 2025
A little "BiTS" of LAG3 agonism, a big effect on T-cell autoimmunity.

Qianqian Ming, Vincent C Luca

|Sep 24, 2025
Engineering synthetic agonists for targeted activation of Notch signaling.

David H Perez, Daniel Antfolk, Shiun Chang

|Jul 02, 2025
Molecular mechanism of Activin receptor inhibition by DLK1.

Daniel Antfolk, Qianqian Ming, Anna Manturova

|Jan 31, 2025
LAG Time in the Era of Immunotherapy-New Molecular Insights Into the Immunosuppression Mechanism of Lymphocyte Activation Gene-3.

Vincent C Luca

|Aug 29, 2024
Structural basis for mouse LAG3 interactions with the MHC class II molecule I-A<sup>b</sup>.

Qianqian Ming, Daniel Antfolk, David A Price

|Aug 16, 2024
Engineering synthetic agonists for targeted activation of Notch signaling.

David H Perez, Daniel Antfolk, Xiomar E Bustos

Pageof 3

Frequent Collaborators

4 joint publications

Qianqian Ming

3 joint publications

Daniel Antfolk

3 joint publications

Elliot Medina

2 joint publications

Anna Manturova